本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

15.04
-0.8500-5.35%
成交量:256.83萬
成交額:3,868.10萬
市值:21.36億
市盈率:-42.75
高:15.88
開:15.88
低:14.78
收:15.89
52周最高:20.22
52周最低:7.92
股本:1.42億
流通股本:1.18億
量比:1.90
換手率:2.18%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.64
市盈率(LYR):-47.40

資料載入中...

2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/21

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]